Determination of globotriaosylceramide in plasma and urine by mass spectrometry
-
Ralf Krüger
Abstract
Background: Fabry disease is an X-chromosomally inherited lysosomal storage disorder leading to accumulation of glycosphingolipids, mainly globotriaosylceramide (ceramide-trihexoside, Gb3). Concentrations of Gb3 in plasma and urine have been used to diagnose Fabry disease and to monitor enzyme replacement therapy with recombinant α-galactosidase.
Methods: Gb3 was purified from plasma or urine by combined liquid extraction/protein precipitation and solid-phase extraction, and was detected by flow-injection analysis electrospray mass spectrometry (MS) using multi-reaction-monitoring. Calibration was performed via standard addition using C17-Gb3 as internal standard. The most abundant isoforms were monitored for calculation of total Gb3.
Results: A MS-based assay for quantification of Gb3 in plasma and urine was established and validated. Intra- and inter-assay coefficient of variation (CV) of the method were ≤12%. However, at low concentrations the CV was 16%. The linear range covers roughly two orders of magnitude, down to 0.54 mg/L in plasma and 0.07 mg/L in urine. Careful adjustment of tuning parameters was necessary to obtain identical isoform intensities and quantitative results on different mass spectrometers. Gb3 concentrations in healthy controls were <4 mg/L in EDTA-plasma and <10 μg/mmol creatinine in urine. Significantly increased Gb3 concentrations were found in plasma and urine from male and female patients with Fabry disease.
Conclusions: An improved MS protocol for Gb3 quantification has been developed, validated, and shown to be suitable for diagnosis and monitoring of Fabry patients.
Clin Chem Lab Med 2010;48:189–98.
©2010 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Review
- Elevated serum γ-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer – a narrative review
- Minireview
- Artificial intelligence for diagnostic purposes: principles, procedures and limitations
- General Clinical Chemistry and Laboratory Medicine
- Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005–2006
- Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults
- Plasma osteopontin concentrations in preeclampsia – is there an association with endothelial injury?
- Determination of globotriaosylceramide in plasma and urine by mass spectrometry
- Effect of inflammation induced by prolonged exercise on circulating erythroid progenitors and markers of erythropoiesis
- The Beckman DxI 800 prolactin assay demonstrates superior specificity for monomeric prolactin
- Stability of cerebrospinal fluid/serum glucose ratio and cerebrospinal fluid lactate concentrations over 24 h: analysis of repeated measurements
- O-β-N-acetyl-D-glucosaminidase in erythrocytes of Italian air force acrobatic pilots
- Validation and Outcome Studies
- Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis
- Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis
- Reference Values and Biological Variations
- Applicability of common reference intervals for serum creatinine concentrations to the Croatian population
- Laboratory reference intervals during pregnancy, delivery and the early postpartum period
- Determination of serum holotranscobalamin concentrations with the AxSYM active B12 assay: cut-off point evaluation in the clinical laboratory
- Definition of reference ranges for the platelet distribution width (PDW): a local need
- Cancer Diagnostics
- Mean leukocyte telomere length and risk of incident colorectal carcinoma in women: a prospective, nested case-control study
- Heat shock protein 27 is over-expressed in tumor tissues and increased in sera of patients with gastric adenocarcinoma
- Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels
- A novel sensitive immunoassay by nucleic acid barcode dot and its application in the detection of prostate-specific antigen
- Prostate cancer screening: clinical impact of WHO calibration of Beckman Coulter Access® prostate-specific antigen assays
- Infectious Diseases
- Use of flow cytometry (Sysmex® UF-100) to screen for positive urine cultures: in search for the ideal cut-off
- Letters to the Editor
- Improving laboratory efficiencies through significant time reduction in the preanalytical phase
- Comparison of the Vitek 2 system with the CLSI broth microdilution, disk diffusion, and sterol quantitation methods for determining fluconazole susceptibility against Candida spp.
Articles in the same Issue
- Review
- Elevated serum γ-glutamyltransferase activity is associated with increased risk of mortality, incident type 2 diabetes, cardiovascular events, chronic kidney disease and cancer – a narrative review
- Minireview
- Artificial intelligence for diagnostic purposes: principles, procedures and limitations
- General Clinical Chemistry and Laboratory Medicine
- Association between serum alkaline phosphatase and C-reactive protein in the United States National Health and Nutrition Examination Survey 2005–2006
- Association between serum uric acid and non-alcoholic fatty liver disease in Korean adults
- Plasma osteopontin concentrations in preeclampsia – is there an association with endothelial injury?
- Determination of globotriaosylceramide in plasma and urine by mass spectrometry
- Effect of inflammation induced by prolonged exercise on circulating erythroid progenitors and markers of erythropoiesis
- The Beckman DxI 800 prolactin assay demonstrates superior specificity for monomeric prolactin
- Stability of cerebrospinal fluid/serum glucose ratio and cerebrospinal fluid lactate concentrations over 24 h: analysis of repeated measurements
- O-β-N-acetyl-D-glucosaminidase in erythrocytes of Italian air force acrobatic pilots
- Validation and Outcome Studies
- Experimental validation of specificity of the squamous cell carcinoma antigen-immunoglobulin M (SCCA-IgM) assay in patients with cirrhosis
- Performance analysis of the ARCHITECT anti-cyclic citrullinated peptide antibody in the diagnosis of rheumatoid arthritis
- Reference Values and Biological Variations
- Applicability of common reference intervals for serum creatinine concentrations to the Croatian population
- Laboratory reference intervals during pregnancy, delivery and the early postpartum period
- Determination of serum holotranscobalamin concentrations with the AxSYM active B12 assay: cut-off point evaluation in the clinical laboratory
- Definition of reference ranges for the platelet distribution width (PDW): a local need
- Cancer Diagnostics
- Mean leukocyte telomere length and risk of incident colorectal carcinoma in women: a prospective, nested case-control study
- Heat shock protein 27 is over-expressed in tumor tissues and increased in sera of patients with gastric adenocarcinoma
- Soluble mesothelin related peptides (SMRP) and osteopontin as protein biomarkers for malignant mesothelioma: analytical validation of ELISA based assays and characterization at mRNA and protein levels
- A novel sensitive immunoassay by nucleic acid barcode dot and its application in the detection of prostate-specific antigen
- Prostate cancer screening: clinical impact of WHO calibration of Beckman Coulter Access® prostate-specific antigen assays
- Infectious Diseases
- Use of flow cytometry (Sysmex® UF-100) to screen for positive urine cultures: in search for the ideal cut-off
- Letters to the Editor
- Improving laboratory efficiencies through significant time reduction in the preanalytical phase
- Comparison of the Vitek 2 system with the CLSI broth microdilution, disk diffusion, and sterol quantitation methods for determining fluconazole susceptibility against Candida spp.